Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Shaffer

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Blood Advances|October 13, 2020
HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantationKattria van der Ploeg, Jean-Benoît Le Luduec, Philip A Stevenson, et al.
Blood Advances|November 29, 2023
Gender disparities in allograft access due to HLA-sensitization in multiparous womenWarren B Fingrut, Eric Davis, Anne Archer, et al.
Cancer Immunology Research|July 8, 2018
Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation AntibodiesJing Chang, Haiyong Peng, Brian C Shaffer, et al.
Blood Advances|October 31, 2023
Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide-based transplantAndrew Lin, Samantha Brown, Stephanie Chinapen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2024
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor TransplantationBrian C Shaffer, Mahasweta Gooptu, Todd DeFor, et al.
Bone Marrow Transplantation|September 8, 2022
CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase eraJohn L Vaughn, Samantha Brown, Esperanza B Papadopoulos, et al.
Experimental Hematology|May 22, 2013
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemiaBrian C Shaffer, Marko Modric, Maryalice Stetler-Stevenson, et al.
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
Blood Advances|May 17, 2023
Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCTKattria van der Ploeg, Rosa Sottile, Theodota Kontopoulos, et al.
Blood Advances|February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawalMark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Blood Advances|October 13, 2020
HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantationKattria van der Ploeg, Jean-Benoît Le Luduec, Philip A Stevenson, et al.
Blood Advances|November 29, 2023
Gender disparities in allograft access due to HLA-sensitization in multiparous womenWarren B Fingrut, Eric Davis, Anne Archer, et al.
Cancer Immunology Research|July 8, 2018
Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation AntibodiesJing Chang, Haiyong Peng, Brian C Shaffer, et al.
Blood Advances|October 31, 2023
Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide-based transplantAndrew Lin, Samantha Brown, Stephanie Chinapen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2024
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor TransplantationBrian C Shaffer, Mahasweta Gooptu, Todd DeFor, et al.
Bone Marrow Transplantation|September 8, 2022
CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase eraJohn L Vaughn, Samantha Brown, Esperanza B Papadopoulos, et al.
Experimental Hematology|May 22, 2013
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemiaBrian C Shaffer, Marko Modric, Maryalice Stetler-Stevenson, et al.
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
Blood Advances|May 17, 2023
Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCTKattria van der Ploeg, Rosa Sottile, Theodota Kontopoulos, et al.
Blood Advances|February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawalMark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Pageof 8